We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Case series reports the use of pegylated interferon‐α‐2a in severe adamantiades‐behçet disease, suggesting positive outcomes.
No takes yet. Share an insight, caveat, or question.
Altenburg et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: